Beam Therapeutics Inc BEAM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:09 PM EDT
22.35quote price arrow up+0.61 (+2.81%)
Volume
357,142
52 week range
16.95 - 49.50
Loading...
  • Open22.08
  • Day High22.68
  • Day Low22.00
  • Prev Close21.74
  • 52 Week High49.50
  • 52 Week High Date02/27/24
  • 52 Week Low16.95
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap1.84B
  • Shares Out82.31M
  • 10 Day Average Volume1.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-17.73

KEY STATS

  • Open22.08
  • Day High22.68
  • Day Low22.00
  • Prev Close21.74
  • 52 Week High49.50
  • 52 Week High Date02/27/24
  • 52 Week Low16.95
  • 52 Week Low Date10/23/23
  • Market Cap1.84B
  • Shares Out82.31M
  • 10 Day Average Volume1.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.87
  • YTD % Change-17.73

RATIOS/PROFITABILITY

  • EPS (TTM)-1.87
  • P/E (TTM)-11.95
  • Fwd P/E (NTM)-4.05
  • EBITDA (TTM)-156.473M
  • ROE (TTM)-15.46%
  • Revenue (TTM)377.709M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-35.09%
  • Debt To Equity (MRQ)0.05%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beam Therapeutics Inc

 

Profile

MORE
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it...
John Evans
Chief Executive Officer, Director
Giuseppe Ciaramella Ph.D.
President
Terry-Ann Burrell
Chief Financial Officer, Treasurer
Address
238 Main Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
CPRX
Catalyst Pharmaceuticals Inc
15.11-0.09-0.59%
VCYT
Veracyte Inc
20.06-0.07-0.35%
TWST
Twist Bioscience Corp
31.52-0.44-1.36%
DNLI
Denali Therapeutics Inc
16.42+0.26+1.61%
ZLAB
Zai Lab Ltd
16.52+0.62+3.93%